Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Supplementation of Zinc, Glutamine, Fiber, and Prebiotics in Presumed Healthy Indonesian Children Aged 1-3 Years

  • Kadim, Muzal (Department of Child Health, Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo Hospital) ;
  • Hegar, Badriul (Department of Child Health, Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo Hospital) ;
  • Bardosono, Saptawati (Department of Nutrition, Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo Hospital) ;
  • Timan, Ina S (Department of Clinical Phatology Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo Hospital) ;
  • Gunardi, Hartono (Department of Child Health, Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo Hospital) ;
  • Prasetyo, Dwi (Department of Child Health, Faculty of Medicine, Padjadjaran University) ;
  • Firmansyah, Agus (Department of Child Health, Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo Hospital) ;
  • Vandenplas, Yvan (KidZ Health Castle, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel)
  • Received : 2019.11.12
  • Accepted : 2020.03.01
  • Published : 2020.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Impaired intestinal mucosal integrity may affect the gastrointestinal function, especially in relation to nutrition, absorption, and barrier function. The purpose of this study was to measure the prevalence of impaired intestinal mucosal integrity in presumed healthy children aged 1-3 years and assess the effects of zinc, glutamine, fiber, and prebiotic supplementation in them. Methods: A cross-sectional study was conducted in 200 children aged 1-3 years in Pasar Minggu, South Jakarta, Indonesia. A randomized double-blind parallel group method clinical trial was then performed to assess the effects of zinc, glutamine, fiber, and prebiotic supplementation. Results: Elevated calprotectin was found in 91/200 subjects (45.5%) at the onset of the study. After 10 months, 144 subjects completed the study: 72 subjects received the trial formula, whereas the other 72 received the standard formula. A transitory decrease in fecal calprotectin (FC) was observed after 6 months in the subgroup with normal FC levels, who were fed the test formula (p=0.012). Conclusion: The prevalence of impaired intestinal mucosal integrity in this group of Indonesian children aged 1-3 years was high. Supplementation with zinc, glutamine, fiber, and prebiotics during 6 months reduced FC only in those who had low levels at baseline but not in those with impaired integrity.

Keywords

References

  1. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. Hasil Utama RISKESDAS 2018. Jakarta: Kementerian Kesehatan Republik Indonesia, 2018.
  2. Lebenthal E. Prolonged small intestinal mucosal injury as a primary cause of intractable diarrhea of infancy. In: Lebenthal E, ed. Chronic diarrhea in children. New York: Raven Press, 1984:5-9.
  3. Duggan C, Gannon J, Walker WA. Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 2002;75:789-808. https://doi.org/10.1093/ajcn/75.5.789
  4. Dijkhuizen MA, Wieringa FT, West CE, Muherdiyantiningsih, Muhilal. Concurrent micronutrient deficiencies in lactating mothers and their infants in Indonesia. Am J Clin Nutr 2001;73:786-91.
  5. Folwaczny C. Zinc and diarrhea in infants. J Trace Elem Med Biol 1997;11:116-22. https://doi.org/10.1016/S0946-672X(97)80036-3
  6. Black RE. Zinc deficiency, infectious disease and mortality in the developing world. J Nutr 2003;133(5 Suppl 1):1485S-9S. https://doi.org/10.1093/jn/133.5.1485S
  7. Lima AA, Brito LF, Ribeiro HB, Martins MC, Lustosa AP, Rocha EM, et al. Intestinal barrier function and weight gain in malnourished children taking glutamine supplemented enteral formula. J Pediatr Gastroenterol Nutr 2005;40:28-35. https://doi.org/10.1097/00005176-200501000-00006
  8. Neu J, DeMarco V, Li N. Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 2002;5:69-75. https://doi.org/10.1097/00075197-200201000-00013
  9. Malkki Y. Physical properties of dietary fiber as keys to physiological functions. Cereal Foods World 2001;46:196-9.
  10. Boehm G, Stahl B. Oligosaccharides. In: Mattila-Sandholm T, ed. Functional dairy products. Volume 1. Cambridge: Woodhead Publishing Ltd, 2003:203-43.
  11. Oord T, Hornung N. Fecal calprotectin in healthy children. Scand J Clin Lab Invest 2014;74:254-8. https://doi.org/10.3109/00365513.2013.879732
  12. Zhu Q, Li F, Wang J, Shen L, Sheng X. Fecal calprotectin in healthy children aged 1-4 years. PLoS One 2016;11:e0150725. https://doi.org/10.1371/journal.pone.0150725
  13. Peura S, Fall T, Almqvist C, Andolf E, Hedman A, Pershagen G, et al. Normal values for calprotectin in stool samples of infants from the population-based longitudinal born into life study. Scand J Clin Lab Invest 2018;78:120-4. https://doi.org/10.1080/00365513.2017.1420216
  14. Lee YM, Min CY, Choi YJ, Jeong SJ. Delivery and feeding mode affects fecal calprotectin levels in infants <7months old. Early Hum Dev 2017;108:45-8. https://doi.org/10.1016/j.earlhumdev.2017.03.014
  15. Noebauer B, Ramic L, Konstantin A, Zachbauer C, Einwallner E. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting. Biochem Med (Zagreb) 2017;27:030710. https://doi.org/10.11613/bm.2017.030710
  16. Li F, Ma J, Geng S, Wang J, Liu J, Zhang J, et al. Fecal calprotectin concentrations in healthy children aged 1-18 months. PLoS One 2015;10:e0119574. https://doi.org/10.1371/journal.pone.0119574
  17. Song JY, Lee YM, Choi YJ, Jeong SJ. Fecal calprotectin level in healthy children aged less than 4 years in South Korea. J Clin Lab Anal 2017;31:e22113. https://doi.org/10.1002/jcla.22113
  18. Velasco Rodriguez-Belvis M, Viada Bris JF, Plata Fernandez C, Garcia-Salido A, Asensio Anton J, Dominguez Ortega G, et al. Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age. Paediatr Child Health 2019.
  19. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009;9:799-809. https://doi.org/10.1038/nri2653
  20. Catalioto RM, Maggi CA, Giuliani S. Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Curr Med Chem 2011;18:398-426. https://doi.org/10.2174/092986711794839179
  21. Larson CP, Roy SK, Khan AI, Rahman AS, Qadri F. Zinc treatment to under-five children: applications to improve child survival and reduce burden of disease. J Health Popul Nutr 2008;26:356-65.
  22. Guerrant RL, Oria RB, Moore SR, Oria MO, Lima AA. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 2008;66:487-505. https://doi.org/10.1111/j.1753-4887.2008.00082.x
  23. Mayo-Wilson E, Junior JA, Imdad A, Dean S, Chan XH, Chan ES, et al. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev 2014;(5):CD009384.